#BEGIN_DRUGCARD DB08357

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C8H18O3

# Chemical_IUPAC_Name:
1-ethoxy-2-(2-ethoxyethoxy)ethane

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:31:04 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE

# HET_ID:
P4G

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C8H18O3/c1-3-9-5-7-11-8-6-10-4-2/h3-8H2,1-2H3

# InChI_Key:
InChIKey=RRQYJINTUHWNHW-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
8363

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
162.2267

# Molecular_Weight_Mono:
162.125594442

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.64

# Predicted_LogS:
-1.1

# Predicted_Water_Solubility:
1.14e+01 g/l

# Primary_Accession_No:
DB08357

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
8179

# PubChem_Substance_ID:
99444828

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCOCCOCCOCC

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:26:45 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
ACHE

# Drug_Target_1_GenBank_ID_Gene:
M55040

# Drug_Target_1_GenBank_ID_Protein:
177975

# Drug_Target_1_GeneCard_ID:
ACHE

# Drug_Target_1_Gene_Name:
ACHE

# Drug_Target_1_Gene_Sequence:
>1845 bp
ATGAGGCCCCCGCAGTGTCTGCTGCACACGCCTTCCCTGGCTTCCCCACTCCTTCTCCTC
CTCCTCTGGCTCCTGGGTGGAGGAGTGGGGGCTGAGGGCCGGGAGGATGCAGAGCTGCTG
GTGACGGTGCGTGGGGGCCGGCTGCGGGGCATTCGCCTGAAGACCCCCGGGGGCCCTGTC
TCTGCTTTCCTGGGCATCCCCTTTGCGGAGCCACCCATGGGACCCCGTCGCTTTCTGCCA
CCGGAGCCCAAGCAGCCTTGGTCAGGGGTGGTAGACGCTACAACCTTCCAGAGTGTCTGC
TACCAATATGTGGACACCCTATACCCAGGTTTTGAGGGCACCGAGATGTGGAACCCCAAC
CGTGAGCTGAGCGAGGACTGCCTGTACCTCAACGTGTGGACACCATACCCCCGGCCTACA
TCCCCCACCCCTGTCCTCGTCTGGATCTATGGGGGTGGCTTCTACAGTGGGGCCTCCTCC
TTGGACGTGTACGATGGCCGCTTCTTGGTACAGGCCGAGAGGACTGTGCTGGTGTCCATG
AACTACCGGGTGGGAGCCTTTGGCTTCCTGGCCCTGCCGGGGAGCCGAGAGGCCCCGGGC
AATGTGGGTCTCCTGGATCAGAGGCTGGCCCTGCAGTGGGTGCAGGAGAACGTGGCAGCC
TTCGGGGGTGACCCGACATCAGTGACGCTGTTTGGGGAGAGCGCGGGAGCCGCCTCGGTG
GGCATGCACCTGCTGTCCCCGCCCAGCCGGGGCCTGTTCCACAGGGCCGTGCTGCAGAGC
GGTGCCCCCAATGGACCCTGGGCCACGGTGGGCATGGGAGAGGCCCGTCGCAGGGCCACG
CAGCTGGCCCACCTTGTGGGCTGTCCTCCAGGCGGCACTGGTGGGAATGACACAGAGCTG
GTAGCCTGCCTTCGGACACGACCAGCGCAGGTCCTGGTGAACCACGAATGGCACGTGCTG
CCTCAAGAAAGCGTCTTCCGGTTCTCCTTCGTGCCTGTGGTAGATGGAGACTTCCTCAGT
GACACCCCAGAGGCCCTCATCAACGCGGGAGACTTCCACGGCCTGCAGGTGCTGGTGGGT
GTGGTGAAGGATGAGGGCTCGTATTTTCTGGTTTACGGGGCCCCAGGCTTCAGCAAAGAC
AACGAGTCTCTCATCAGCCGGGCCGAGTTCCTGGCCGGGGTGCGGGTCGGGGTTCCCCAG
GTAAGTGACCTGGCAGCCGAGGCTGTGGTCCTGCATTACACAGACTGGCTGCATCCCGAG
GACCCGGCACGCCTGAGGGAGGCCCTGAGCGATGTGGTGGGCGACCACAATGTCGTGTGC
CCCGTGGCCCAGCTGGCTGGGCGACTGGCTGCCCAGGGTGCCCGGGTCTACGCCTACGTC
TTTGAACACCGTGCTTCCACGCTCTCCTGGCCCCTGTGGATGGGGGTGCCCCACGGCTAC
GAGATCGAGTTCATCTTTGGGATCCCCCTGGACCCCTCTCGAAACTACACGGCAGAGGAG
AAAATCTTCGCCCAGCGACTGATGCGATACTGGGCCAACTTTGCCCGCACAGGGGATCCC
AATGAGCCCCGAGACCCCAAGGCCCCACAATGGCCCCCGTACACGGCGGGGGCTCAGCAG
TACGTTAGTCTGGACCTGCGGCCGCTGGAGGTGCGGCGGGGGCTGCGCGCCCAGGCCTGC
GCCTTCTGGAACCGCTTCCTCCCCAAATTGCTCAGCGCCACCGACACGCTCGACGAGGCG
GAGCGCCAGTGGAAGGCCGAGTTCCACCGCTGGAGCTCCTACATGGTGCACTGGAAGAAC
CAGTTCGACCACTACAGCAAGCAGGATCGCTGCTCAGACCTGTGA

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
11053835	Kryger G, Harel M, Giles K, Toker L, Velan B, Lazar A, Kronman C, Barak D, Ariel N, Shafferman A, Silman I, Sussman JL: Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallogr D Biol Crystallogr. 2000 Nov;56(Pt 11):1385-94.
11239002	Wilson MD, Riemer C, Martindale DW, Schnupf P, Boright AP, Cheung TL, Hardy DM, Schwartz S, Scherer SW, Tsui LC, Miller W, Koop BF: Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5. Nucleic Acids Res. 2001 Mar 15;29(6):1352-65.
12853948	Hillier LW, Fulton RS, Fulton LA, Graves TA, Pepin KH, Wagner-McPherson C, Layman D, Maas J, Jaeger S, Walker R, Wylie K, Sekhon M, Becker MC, O'Laughlin MD, Schaller ME, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Cordes M, Du H, Sun H, Edwards J, Bradshaw-Cordum H, Ali J, Andrews S, Isak A, Vanbrunt A, Nguyen C, Du F, Lamar B, Courtney L, Kalicki J, Ozersky P, Bielicki L, Scott K, Holmes A, Harkins R, Harris A, Strong CM, Hou S, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Leonard S, Rohlfing T, Rock SM, Tin-Wollam AM, Abbott A, Minx P, Maupin R, Strowmatt C, Latreille P, Miller N, Johnson D, Murray J, Woessner JP, Wendl MC, Yang SP, Schultz BR, Wallis JW, Spieth J, Bieri TA, Nelson JO, Berkowicz N, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Bedell JA, Mardis ER, Clifton SW, Chissoe SL, Marra MA, Raymond C, Haugen E, Gillett W, Zhou Y, James R, Phelps K, Iadanoto S, Bubb K, Simms E, Levy R, Clendenning J, Kaul R, Kent WJ, Furey TS, Baertsch RA, Brent MR, Keibler E, Flicek P, Bork P, Suyama M, Bailey JA, Portnoy ME, Torrents D, Chinwalla AT, Gish WR, Eddy SR, McPherson JD, Olson MV, Eichler EE, Green ED, Waterston RH, Wilson RK: The DNA sequence of human chromosome 7. Nature. 2003 Jul 10;424(6945):157-64.
1517212	Shafferman A, Kronman C, Flashner Y, Leitner M, Grosfeld H, Ordentlich A, Gozes Y, Cohen S, Ariel N, Barak D, et al.: Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding. J Biol Chem. 1992 Sep 5;267(25):17640-8.
1748670	Velan B, Grosfeld H, Kronman C, Leitner M, Gozes Y, Lazar A, Flashner Y, Marcus D, Cohen S, Shafferman A: The effect of elimination of intersubunit disulfide bonds on the activity, assembly, and secretion of recombinant human acetylcholinesterase. Expression of acetylcholinesterase Cys-580----Ala mutant. J Biol Chem. 1991 Dec 15;266(35):23977-84.
2263619	Soreq H, Ben-Aziz R, Prody CA, Seidman S, Gnatt A, Neville L, Lieman-Hurwitz J, Lev-Lehman E, Ginzberg D, Lipidot-Lifson Y, et al.: Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9688-92.
2714437	Chhajlani V, Derr D, Earles B, Schmell E, August T: Purification and partial amino acid sequence analysis of human erythrocyte acetylcholinesterase. FEBS Lett. 1989 Apr 24;247(2):279-82.
8299725	Karpel R, Ben Aziz-Aloya R, Sternfeld M, Ehrlich G, Ginzberg D, Tarroni P, Clementi F, Zakut H, Soreq H: Expression of three alternative acetylcholinesterase messenger RNAs in human tumor cell lines of different tissue origins. Exp Cell Res. 1994 Feb;210(2):268-77.
8488842	Bartels CF, Zelinski T, Lockridge O: Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am J Hum Genet. 1993 May;52(5):928-36.
9640563	Felder CE, Botti SA, Lifson S, Silman I, Sussman JL: External and internal electrostatic potentials of cholinesterase models. J Mol Graph Model. 1997 Oct;15(5):318-27, 335-7.

# Drug_Target_1_HGNC_ID:
HGNC:108

# Drug_Target_1_HPRD_ID:
00010

# Drug_Target_1_ID:
474

# Drug_Target_1_Locus:
7q22

# Drug_Target_1_Molecular_Weight:
67797

# Drug_Target_1_Name:
Acetylcholinesterase

# Drug_Target_1_Number_of_Residues:
614

# Drug_Target_1_PDB_ID:
1F8U

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00135	COesterase

# Drug_Target_1_Protein_Sequence:
>Acetylcholinesterase precursor
MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGGRLRGIRLKTPGGPV
SAFLGIPFAEPPMGPRRFLPPEPKQPWSGVVDATTFQSVCYQYVDTLYPGFEGTEMWNPN
RELSEDCLYLNVWTPYPRPTSPTPVLVWIYGGGFYSGASSLDVYDGRFLVQAERTVLVSM
NYRVGAFGFLALPGSREAPGNVGLLDQRLALQWVQENVAAFGGDPTSVTLFGESAGAASV
GMHLLSPPSRGLFHRAVLQSGAPNGPWATVGMGEARRRATQLAHLVGCPPGGTGGNDTEL
VACLRTRPAQVLVNHEWHVLPQESVFRFSFVPVVDGDFLSDTPEALINAGDFHGLQVLVG
VVKDEGSYFLVYGAPGFSKDNESLISRAEFLAGVRVGVPQVSDLAAEAVVLHYTDWLHPE
DPARLREALSDVVGDHNVVCPVAQLAGRLAAQGARVYAYVFEHRASTLSWPLWMGVPHGY
EIEFIFGIPLDPSRNYTAEEKIFAQRLMRYWANFARTGDPNEPRDPKAPQWPPYTAGAQQ
YVSLDLRPLEVRRGLRAQACAFWNRFLPKLLSATDTLDEAERQWKAEFHRWSSYMVHWKN
QFDHYSKQDRCSDL

# Drug_Target_1_Reaction:
acetylcholine + H2O = choline + acetate

# Drug_Target_1_Signals:
1-31

# Drug_Target_1_Specific_Function:
Rapidly hydrolyzes choline released into the synapse

# Drug_Target_1_SwissProt_ID:
P22303

# Drug_Target_1_SwissProt_Name:
ACES_HUMAN

# Drug_Target_1_Synonyms:
AChE
Acetylcholinesterase precursor
EC 3.1.1.7

# Drug_Target_1_Theoretical_pI:
6.24

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cell membrane

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
L19954

# Drug_Target_2_GenBank_ID_Protein:
438455

# Drug_Target_2_GeneCard_ID:
ybbD

# Drug_Target_2_Gene_Name:
ybbD

# Drug_Target_2_Gene_Sequence:
>1929 bp
ATGAGACCTGTCTTTCCGCTTATCCTTTCAGCCGTTCTCTTTCTTTCATGCTTTTTCGGG
GCCAGACAGACAGAAGCCTCTGCATCCAAACGTGCAATCGATGCCAATCAGATTGTCAAT
CGTATGTCGTTAGATGAAAAACTCGGCCAGATGCTGATGCCTGATTTTAGAAATTGGCAA
AAGGAAGGCGAGTCCTCTCCGCAAGCCCTTACAAAAATGAATGATGAAGTCGCCAGCCTC
GTCAAGAAATATCAATTCGGAGGCATCATCCTTTTTGCAGAAAATGTAAAAACAACAAAA
CAAACTGTCCAACTGACAGACGATTACCAAAAGGCAAGTCCAAAAATCCCGCTCATGCTG
AGTATTGATCAGGAAGGCGGCATTGTAACGAGGTTAGGGGAGGGCACTAATTTCCCAGGG
AATATGGCGCTGGGCGCAGCCAGAAGCAGAATCAATGCGTATCAGACCGGCAGCATCATC
GGAAAAGAGCTCTCTGCCTTAGGCATCAATACAGATTTCAGCCCTGTCGTGGACATTAAC
AATAATCCTGATAATCCTGTAATCGGCGTACGGTCATTCAGCTCCAATCGAGAACTGACA
TCACGCCTCGGTTTATATACGATGAAAGGGTTGCAGCGGCAGGATATCGCGTCTGCCCTC
AAACATTTCCCGGGACATGGAGACACGGACGTTGACAGCCATTATGGACTGCCGCTCGTT
TCCCATGGCCAAGAACGGCTTCGTGAGGTCGAGCTTTATCCTTTTCAAAAAGCAATTGAT
GCTGGTGCTGATATGGTGATGACAGCCCATGTTCAGTTTCCCGCCTTTGATGACACCACT
TACAAAAGCAAACTCGATGGATCGGACATTCTGGTTCCAGCTACACTTTCAAAAAAAGTG
ATGACAGGTCTTCTTCGTCAGGAAATGGGCTTTAATGGGGTCATCGTTACCGATGCGCTC
AATATGAAGGCAATCGCAGATCATTTCGGACAGGAAGAGGCTGTGGTCATGGCCGTAAAA
GCTGGTGTCGATATTGCATTAATGCCAGCCTCAGTCACTTCATTGAAAGAAGAACAGAAA
TTCGCACGTGTTATTCAAGCTTTGAAAGAAGCCGTGAAAAACGGGGATATTCCTGAACAA
CAAATCAACAATTCAGTTGAAAGAATCATTTCCCTGAAAATAAAACGCGGCATGTATCCA
GCGCGAAACAGCGACAGTACAAAAGAAAAAATAGCCAAAGCCAAAAAAATCGTAGGAAGC
AAGCAGCACCTGAAAGCAGAGAAAAAATTAGCTGAAAAAGCAGTAACTGTATTAAAAAAT
GAACAGCACACTTTGCCGTTCAAGCCTAAAAAAGGCAGCCGAATCTTAATTGTGGCACCT
TACGAAGAACAAACTGCTTCAATCGAACAAACCATTCACGATCTCATCAAGCGAAAGAAA
ATCAAACCCGTATCCCTCAGCAAAATGAACTTTGCCAGCCAAGTATTTAAGACCGAGCAT
GAAAAACAAGTAAAAGAGGCTGATTATATCATTACCGGCTCCTATGTCGTCAAAAATGAC
CCTGTCGTCAACGACGGTGTCATCGACGACACAATATCAGATTCAAGCAAATGGGCCACC
GTGTTTCCGAGAGCTGTCATGAAAGCCGCACTGCAGCACAACAAACCATTTGTCTTAATG
AGCCTGCGCAACCCCTATGACGCAGCCAATTTCGAAGAAGCAAAAGCACTGATTGCAGTC
TATGGCTTTAAAGGATACGCAAATGGCCGTTATCTTCAACCTAATATTCCGGCCGGAGTG
ATGGCGATATTCGGCCAGGCAAAACCTAAAGGCACACTTCCAGTTGACATTCCGTCAGTC
ACGAAACCAGGGAACACCCTTTACCCACTTGGCTACGGATTAAATATCAAAACGGGAAGA
CCGCTTTAA

# Drug_Target_2_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_2_General_References:
8011666	Quirk PG, Guffanti AA, Clejan S, Cheng J, Krulwich TA: Isolation of Tn917 insertional mutants of Bacillus subtilis that are resistant to the protonophore carbonyl cyanide m-chlorophenylhydrazone. Biochim Biophys Acta. 1994 Jun 28;1186(1-2):27-34.
9274029	Liu H, Haga K, Yasumoto K, Ohashi Y, Yoshikawa H, Takahashi H: Sequence and analysis of a 31 kb segment of the Bacillus subtilis chromosome in the area of the rrnH and rrnG operons. Microbiology. 1997 Aug;143 ( Pt 8):2763-7.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6794

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
70579.9

# Drug_Target_2_Name:
Uncharacterized lipoprotein ybbD

# Drug_Target_2_Number_of_Residues:
642

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00933	Glyco_hydro_3
PF01915	Glyco_hydro_3_C

# Drug_Target_2_Protein_Sequence:
>Uncharacterized lipoprotein ybbD
MRPVFPLILSAVLFLSCFFGARQTEASASKRAIDANQIVNRMSLDEKLGQMLMPDFRNWQ
KEGESSPQALTKMNDEVASLVKKYQFGGIILFAENVKTTKQTVQLTDDYQKASPKIPLML
SIDQEGGIVTRLGEGTNFPGNMALGAARSRINAYQTGSIIGKELSALGINTDFSPVVDIN
NNPDNPVIGVRSFSSNRELTSRLGLYTMKGLQRQDIASALKHFPGHGDTDVDSHYGLPLV
SHGQERLREVELYPFQKAIDAGADMVMTAHVQFPAFDDTTYKSKLDGSDILVPATLSKKV
MTGLLRQEMGFNGVIVTDALNMKAIADHFGQEEAVVMAVKAGVDIALMPASVTSLKEEQK
FARVIQALKEAVKNGDIPEQQINNSVERIISLKIKRGMYPARNSDSTKEKIAKAKKIVGS
KQHLKAEKKLAEKAVTVLKNEQHTLPFKPKKGSRILIVAPYEEQTASIEQTIHDLIKRKK
IKPVSLSKMNFASQVFKTEHEKQVKEADYIITGSYVVKNDPVVNDGVIDDTISDSSKWAT
VFPRAVMKAALQHNKPFVLMSLRNPYDAANFEEAKALIAVYGFKGYANGRYLQPNIPAGV
MAIFGQAKPKGTLPVDIPSVTKPGNTLYPLGYGLNIKTGRPL

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
1-16

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
P40406

# Drug_Target_2_SwissProt_Name:
YBBD_BACSU

# Drug_Target_2_Synonyms:
ORF1

# Drug_Target_2_Theoretical_pI:
9.94

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cytoplasmic

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
CR543861

# Drug_Target_3_GenBank_ID_Protein:
49529274

# Drug_Target_3_GeneCard_ID:
ptsP

# Drug_Target_3_Gene_Name:
ptsP

# Drug_Target_3_Gene_Sequence:
>1398 bp
ATGCTTTGGACAGACTGCTTAACTCGCTTGCGACAAGAGCTATCTGATAACGTCTTTGCG
ATGTGGATTCGTCCTTTAGTAGCTGAAGAGACGACAGATAGTCTACGCCTGTATGCGCCG
AACCCTTACTGGACGCGTTATATTCAGGAACATCATCTTGAGTTGATCTCTATTCTGGTT
GAACAACTTTCTGAAGGGCGGATTCGCCAGGTCGAAATTTTGGTTGACTCGCGTCCTGGT
GCAATTTTATCCCCAGCAGAACAGCCAGCGACAACCACTGCTGCTCTGTCAAGTACACCA
GTTGTACCTCAGCGCGTTAAAAAAGAAGTTGTCGAACCAGCAGCTACGCAAAGTAATAAA
ATTTTAAATTCAAAAAAACGTTTACTTAACCCACTGTTTACCTTCTCATTGTTTGTCGAG
GGCCGTTCTAACCAGATGGCTGCTGAGACTTGCCGAAAAGTTTTAACTCAACTTGGTGCC
TCCCAGCACAATCCTTTGTTTTTATATGGCCCGACAGGTTTAGGTAAAACTCACTTGATG
CAGGCTGTGGGTAACGCATTACTTCAAGCCAAACCAAATGCACGTGTGATGTATATGACG
GCAGAAAGTTTTGTACAGGATTTTGTGAGCTCGTTACAAAAAGGCAAGGTTGAAGAGTTT
AAGAAAAACTGTCGTTCACTTGATCTACTTTTGGTCGATGACATTCACTTGCTGGCGGGT
AAAGAAGCCAGTCTGGTCGAATTTTTCTATACCTTTAACGCCCTATTGGATGAATCTAAA
CAGATTATTTTAACTTCAGACCGTTATCCAAAAGAATTAACCGAGCTGGATCCGCGTCTG
GTGTCACGTTTTTCTTGGGGATTATCTGTTGGTGTTGAGCCACCAGATATTGAAACGCGT
ATCGAGATTTTGCTTAAAAAAGCAGAAAATAGCGGTGTGGATTTACCTCGTAATTGTGCA
TTGTTTATTGCCCAGCAAGTGGTGGCCAATGTACGTGAACTGGAAGGTGCACTCAATAAA
GTCGTAGCAATTGCACGTTTTAAAGGTTCACAGATCGATTTGGATGTGGTGCGTGAATCC
CTTAAAGATGTATTGGCGATTCGTGCGCGAACCATTAGTGTGGAAAATATTCAGCGTGTG
GTCAGCGAATATTTTCGTATTCCGCTCAAAGAGTTGATTGGACCGAAGCGGACACGTATC
TATGCGCGTCCACGCCAGCTGGCGATGGGATTGGCACGTGAACTGACAGGCGATAGTTTC
CCTGAAATTGGGATGGCTTTTGGCGGACGCGATCACAGTACAGTGATGCACGCCTGTGAA
AAAGTACAGAGCTTAAAACAAGAAGATCCAATTTTTAATGAGGATTATAAAAACCTGTTG
CGCTTATTACAGAGTTAA

# Drug_Target_3_General_Function:
Signal transduction mechanisms

# Drug_Target_3_General_References:
15514110	Barbe V, Vallenet D, Fonknechten N, Kreimeyer A, Oztas S, Labarre L, Cruveiller S, Robert C, Duprat S, Wincker P, Ornston LN, Weissenbach J, Marliere P, Cohen GN, Medigue C: Unique features revealed by the genome sequence of Acinetobacter sp. ADP1, a versatile and naturally transformation competent bacterium. Nucleic Acids Res. 2004 Oct 28;32(19):5766-79. Print 2004.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6795

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
85543.4

# Drug_Target_3_Name:
Phosphoenolpyruvate-protein phosphotransferase

# Drug_Target_3_Number_of_Residues:
764

# Drug_Target_3_PDB_ID:
Not Available

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF00391	PEP-utilizers
PF01590	GAF
PF02896	PEP-utilizers_C
PF05524	PEP-utilisers_N

# Drug_Target_3_Protein_Sequence:
>Phosphoenolpyruvate-protein phosphotransferase
MSNMQLDTLRRIVQEINSSVSLHDSLDIMVNQVADAMKVDVCSIYLLDERNQRYLLMASK
GLNPESVGHVSLQLSEGLVGLVGQREEIVNLENASKHERFAYLPETGEEIYNSFLGVPVM
YRRKVMGVLVVQNKQPQDFSEAAESFLVTLCAQLSGVIAHAHAVGNIDVFRKPSNGATYK
TFQGVPGSGGIALGRAIVLYPPADLASVPDREAEDISDELQLLDQAVSSVRTEIQQLDEK
MQDSLMSEERALFSVFLRMLDENALPAEIKELIRAGNWAQGAVRRVIDKHITLFAQMEDD
YLRERVSDLKDLGRRILASLQEADSSHREISPDSIIIGEEISTAALVELPVDNIAAIVTT
EGAANSHMVIVARALGIPTVVGVTELPINTLDDAEMIVDAYQGRIFINPPRRMRQRYKEI
QKEEEQIAKDLKQYETRDAITPDGVAVRLYVNTGLMIDVVRGVQRGAKGVGLYRSEIPFM
LRDRFPGEEEQRAMYRQQLSHFANKPVTMRTLDIGADKDLPYFSIEEENSALGWRGLRFT
LDHPEIFSTQVRAMLKASIGLNNLHILLPMVTSVSEVEEVLYLVERDWNAVQEEEQVKIT
KPKIGIMVEVPSVLLQIDEFSELVDFFSVGSNDLIQYLLAVDRNNPRVSSVYSHFHPSVL
RALQRLVKDCHKYEKPVSICGEMAGDPLSAILLMAMGFNTLSMSSSNILRVRKAICHVAM
SDAEKLLSEVVKMNNPLMVKSWIEYYFKNHGLGDMVKSNRLVSV

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Not Available

# Drug_Target_3_SwissProt_ID:
Q6FEW8

# Drug_Target_3_SwissProt_Name:
Q6FEW8_ACIAD

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
4.99

# Drug_Target_3_Transmembrane_Regions:
None

#END_DRUGCARD DB08357
